Researchers have created an AI tool that uses CT imaging to predict the spread risk of oropharyngeal cancer, offering improved treatment stratification.
Key Details
- 1Developed and validated by Mass General Brigham and Dana-Farber Cancer Institute.
- 2AI tool predicts likelihood of lymph node extranodal extension (ENE) using CT scans.
- 3Tested on imaging data from 1,733 patients with oropharyngeal carcinoma.
- 4Integration of AI assessment improved risk stratification for survival and cancer spread.
- 5Could guide both escalation and de-escalation of treatment strategies.
- 6Published in Journal of Clinical Oncology (DOI: 10.1200/JCO-24-02679).
Why It Matters
This tool offers a noninvasive approach for more accurate prognosis and tailored therapies in head and neck cancer, potentially reducing unnecessary interventions and improving outcomes. It demonstrates a significant advance in leveraging imaging AI for complex cancer management decisions.
Source
EurekAlert
Related News
•EurekAlert
UVA's $4M NIH Grant Backs AI to Optimize Cardiac MRI Therapies
UVA secures $4 million NIH funding to develop GenStrain, an AI model using MRI data to personalize cardiac pacing therapies.
•EurekAlert
Machine Learning Models Predict Cancer Risk with Routine Health Data
Researchers developed machine learning models using routinely collected health data to predict individual risk for 20 common cancers, outperforming traditional methods for several cancer types.
•EurekAlert
Duke Receives $25M to Lead National Trustworthy AI Hub for Dementia and Aging
Duke University has launched a $25 million national center to make AI for aging and dementia clinically robust and trustworthy.